Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.06.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Valérie Jooste und 3 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Cancer Registry of Burgundy, Dijon, France; CTM UMR1231 EPICAD, Dijon, France; Department of Digestive Oncology, University Hospital Dijon,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Lung Neoplasms, Peritoneal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Population-based data on the incidence of frequent colorectal metastases are fairly scarce, while that on rare metastatic sites are lacking. AIMS: The aim of this study was to provide epidemiological indicators of metastatic sites frequency in patients with colorectal cancer. METHODS: Incidence was modelled using Poisson and Joinpoint regressions in a population-based cancer registry study including metastatic colorectal cancers diagnosed between 1991 and 2020 (N = 5,199). Tumor molecular markers were collected for the [2016-2020] period. RESULTS: Liver, peritoneum, lung and bone were the most frequent metastatic sites. Among frequent sites, incidence of liver and lung sites decreased in men respectively since 1999 and 2010, whereas in women incidence of liver and peritoneum sites increased steadily throughout the whole period. Each of the other sites concerned less than 3% of metastatic colorectal cancer cases and presented standardized incidence rates between 0.19 and 1.39 per 1,000,000. Among rare sites, incidence of adrenal glands, supraclavicular lymph node, mediastinum and ascites had doubled in [2016-2020] as compared to the 25 previous years. BRAFV600E variant was more frequent in presence of carcinomatosis, and absence of liver and lung metastasis while KRAS variant was more frequent in presence of lung metastasis. CONCLUSION: This study provides unprecedented incidence indicators for rare synchronous metastases of colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Cancer Registry of Burgundy, Dijon, France; CTM UMR1231 EPICAD, Dijon, France; Department of Digestive Oncology, University Hospital Dijon, France; University of Burgundy, France.
- CTM UMR1231 EPICAD, Dijon, France; Department of Digestive Oncology, University Hospital Dijon, France; University of Burgundy, France.
- Digestive Cancer Registry of Burgundy, Dijon, France; CTM UMR1231 EPICAD, Dijon, France; Department of Digestive Oncology, University Hospital Dijon, France; University of Burgundy, France. Electronic address: anne-mari…
Zitieren
APA
Jooste, V., Lepage, C., Manfredi, S., & Bouvier, A. M. (2025). Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.06.018
Vancouver
Jooste V, Lepage C, Manfredi S, Bouvier AM. Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.06.018
BibTeX
@article{Jooste2025,
author = {Jooste, Valérie and Lepage, Côme and Manfredi, Sylvain and Bouvier, Anne-Marie},
title = {Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.06.018}
}
EUVIMED